Mitral annular calcification (MAC) is a progressive, degenerative process increasingly recognised for its clinical impact.

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach ...

The US Food and Drug Administration has approved the Sapien M3 system for transseptal transcatheter mitral valve replacement (TMVR) for use in patients with symptomatic moderate-to-severe mitral ...

What Is Mitral Valve Prolapse? Mitral valve prolapse is a common heart condition. It happens when there’s a problem with how one of the heart's valves works. Heart valves keep blood moving through the ...

QUEBEC CITY — Although women appear to benefit as much as men do from left atrial appendage occlusion (LAAO) during surgery for atrial fibrillation (AF), they have far worse 30-day outcomes following ...

ATLANTA, Oct. 22, 2025 /PRNewswire/ -- Nyra Medical, a leading innovator in structural heart therapies, announced today the initiation of its first-in-human clinical study evaluating its novel Cardiac ...

A team at the Oklahoma Heart Institute is helping patients across the globe with a groundbreaking device that could change how doctors treat mitral valve disease. Developed by Edwards Lifesciences and ...

Chest pain can be triggered by many different conditions and situations, and not all chest pain is equal. Here's what you ...

Patients who underwent mitral valve replacement had a more than threefold higher 10-year rate of infective endocarditis than those at moderate risk for the disease, whereas undergoing mitral valve ...

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation are more than twice as likely to die or be ...

There’s huge movement on the mitral valve landscape this month, as Foldax is reporting reaching a regulatory milestone for the Tria Mitral Valve. The Salt Lake City, UT-based company has won approval ...